- Home
- AMPG vs CVKD Comparison
AMPG vs CVKD Comparison
Compare AMPG & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPG
- CVKD
- Stock Information
- Founded
- AMPG 2002
- CVKD 2022
- Country
- AMPG United States
- CVKD United States
- Employees
- AMPG N/A
- CVKD N/A
- Industry
- AMPG Telecommunications Equipment
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- AMPG Telecommunications
- CVKD Health Care
- Exchange
- AMPG Nasdaq
- CVKD Nasdaq
- Market Cap
- AMPG 29.1M
- CVKD 31.5M
- IPO Year
- AMPG N/A
- CVKD 2023
- Fundamental
- Price
- AMPG $1.79
- CVKD $16.89
- Analyst Decision
- AMPG Strong Buy
- CVKD Strong Buy
- Analyst Count
- AMPG 1
- CVKD 1
- Target Price
- AMPG $5.00
- CVKD $32.00
- AVG Volume (30 Days)
- AMPG 316.6K
- CVKD 20.4K
- Earning Date
- AMPG 05-27-2025
- CVKD 05-08-2025
- Dividend Yield
- AMPG N/A
- CVKD N/A
- EPS Growth
- AMPG N/A
- CVKD N/A
- EPS
- AMPG N/A
- CVKD N/A
- Revenue
- AMPG $9,508,372.00
- CVKD N/A
- Revenue This Year
- AMPG $82.37
- CVKD N/A
- Revenue Next Year
- AMPG $76.47
- CVKD N/A
- P/E Ratio
- AMPG N/A
- CVKD N/A
- Revenue Growth
- AMPG N/A
- CVKD N/A
- 52 Week Low
- AMPG $0.64
- CVKD $5.70
- 52 Week High
- AMPG $6.43
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- AMPG 56.75
- CVKD 51.31
- Support Level
- AMPG $1.42
- CVKD $15.85
- Resistance Level
- AMPG $1.83
- CVKD $17.00
- Average True Range (ATR)
- AMPG 0.17
- CVKD 1.34
- MACD
- AMPG 0.06
- CVKD 0.21
- Stochastic Oscillator
- AMPG 85.48
- CVKD 88.11
About AMPG Amplitech Group Inc.
AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.